ditiocarb has been researched along with allyl sulfide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergquist, F; Engberg, G; Jonason, J; Nissbrandt, H | 1 |
| Bartoli, C; Corsini, GU; Dinucci, D; Pardini, C; Vaglini, F; Viaggi, C | 1 |
2 other study(ies) available for ditiocarb and allyl sulfide
| Article | Year |
|---|---|
Inhibition of cytochrome P450 2E1 induces an increase in extracellular dopamine in rat substantia nigra: a new metabolic pathway?
Topics: 3,4-Dihydroxyphenylacetic Acid; Allyl Compounds; Animals; Antioxidants; Chelating Agents; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Ditiocarb; Dopamine; Energy Metabolism; Enzyme Inhibitors; Extracellular Space; Homovanillic Acid; Isothiocyanates; Male; Microdialysis; Neostriatum; Neurons; Rats; Rats, Sprague-Dawley; Substantia Nigra; Sulfides | 2001 |
Involvement of cytochrome P450 2E1 in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Allyl Compounds; Animals; Blotting, Western; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Disease Models, Animal; Ditiocarb; Dopamine; Drug Synergism; Enzyme Inhibitors; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Neostriatum; Parkinsonian Disorders; Reverse Transcriptase Polymerase Chain Reaction; Substantia Nigra; Sulfides; Tyrosine 3-Monooxygenase | 2004 |